Current Problems in Surgery
Volume 44, Issue 4 , Pages 228-269 , April 2007

Laparoscopic Staging for Liver, Biliary, Pancreas, and Gastric Cancer

  • Michael D’Angelica, MD

      Affiliations

    • Assistant Attending, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Spiros P. Hiotis, MD, PhD

      Affiliations

    • Assistant Professor of Surgery, Bellevue Hospital, New York University School of Medicine, New York, New York
    • ,
  • Hong Jin Kim, MD

      Affiliations

    • Assistant Professor of Surgery/Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine Chapel Hill, North Carolina
    • ,
  • Margo Shoup, MD

      Affiliations

    • Associate Professor of Surgery, Chief, GI Surgical Oncology, Loyola University Medical Center, Maywood, Illinois
    • ,
  • Sharon M. Weber, MD

      Affiliations

    • Associate Professor of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

References 

  1. D’Angelica M, Fong Y, Weber S, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol. 2003;10:183–189
  2. John TG, Greig JD, Crosbie JL, et al. Superior staging of liver-tumors with laparoscopy and laparoscopic ultrasound. Ann Surg. 1994;220:711–719
  3. Ribero D, Abdalla EK, Thomas MB, et al. Liver resection in the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther. 2006;6:567–579
  4. de Castro SMM, Tilleman EHBM, Busch ORC, et al. Diagnostic laparoscopy for primary and secondary liver malignancies: impact of improved imaging and changed criteria for resection. Ann Surg Oncol. 2004;11:522–529
  5. Weitz J, D’Angelica M, Jarnagin W, et al. Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery. 2004;135:273–281
  6. Lo CM. Determining resectability for hepatocellular carcinoma: the role of laparoscopy and laparoscopic ultrasonography. J Hepatobiliary Pancreat Surg. 2000;7:260–264
  7. Klegar EK. Diagnostic laparoscopy in the evaluation of the viral hepatitis patient with potentially resectable hepatocellular carcinoma. HPB Surg. 2005;7:204–207
  8. Lang BHH, Poon RTP, Fan ST, et al. Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection. Br J Surg. 2004;91:444–449
  9. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384–391
  10. Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc Other Intervent Tech. 2006;20:721–725
  11. D’Angelica M, Jarnagin W, DeMatteo R, et al. Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases. Ann Surg Oncol. 2002;9:204–209
  12. Rahusen FD, Cuesta MA, Borgstein PJ, et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg. 1999;230:31–37
  13. Koea J, Rodgers M, Thompson P, et al. Laparoscopy in the management of colorectal cancer metastatic to the liver. ANZ J Surg. 2004;74:1056–1059
  14. Metcalfe MS, Close JS, Iswariah H, et al. The value of laparoscopic staging for patients with colorectal metastases. Arch Surg. 2003;138:770–772
  15. Grobmyer SR, Fong YM, D’Angelica M, et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg. 2004;139:1326–1330
  16. Thaler K, Kanneganti S, Khajanchee Y, et al. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg. 2005;140:727–732
  17. Weber SM, DeMatteo RP, Fong YM, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma—analysis of 100 patients. Ann Surg. 2002;235:392–399
  18. Agrawal S, Sonawane RN, Behari A, et al. Laparoscopic staging in gallbladder cancer. Dig Surg. 2005;22:440–445
  19. Bhargava DK, Sarin S, Verma K, et al. Laparoscopy in carcinoma of the gallbladder. Gastrointest Endosc. 1983;29:21–22
  20. Kriplani AK, Jayant S, Kapur BML. Laparoscopy in primary-carcinoma of the gallbladder. Gastrointest Endosc. 1992;38:326–329
  21. Vollmer CM, Drebin JA, Middleton WD, et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg. 2002;235:1–7
  22. Connor S, Barron E, Wigmore SJ, et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg. 2005;9:476–480
  23. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–517
  24. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30
  25. Conlon KC, Minnard EA. The Value of Laparoscopic Staging in Upper Gastrointestinal Malignancy. Oncologist. 1997;2:10–17
  26. Conlon KC, Brennan MF. Laparoscopy for staging abdominal malignancies. Adv Surg. 2000;34:331–350
  27. Gloor B, Todd KE, Reber HA. Diagnostic workup of patients with suspected pancreatic carcinoma: the University of California-Los Angeles approach. Cancer. 1997;79:1780–1786
  28. Jimenez RE, Warshaw AL, Rattner DW, et al. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg. 2000;135:409–414
  29. Cuschieri A. Laparoscopy for pancreatic-cancer—does it benefit the patient. Eur J Surg Oncol. 1988;14:41–44
  30. Shoup M, Winston C, Brennan MF, et al. Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?. J Gastrointest Surg. 2004;8:1068–1071
  31. Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg. 1993;165:600–606
  32. Dooley WC, Cameron JL, Pitt HA, et al. Is preoperative angiography useful in patients with periampullary tumors?. Ann Surg. 1990;211:649–654
  33. Catheline JM, Turner R, Rizk N, et al. The use of diagnostic laparoscopy supported by laparoscopic ultrasonography in the assessment of pancreatic cancer. Surg Endosc. 1999;13:239–245
  34. Reddy KR, Levi J, Livingstone A, et al. Experience with staging laparoscopy in pancreatic malignancy. Gastrointest Endosc. 1999;49:498–503
  35. Warshaw AL, Tepper JE, Shipley WU. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg. 1986;151:76–80
  36. Warshaw AL, Gu ZY, Wittenberg J, et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 1990;125:230–233
  37. Fernandezdelcastillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic-cancer. Br J Surg. 1995;82:1127–1129
  38. Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19:638–642
  39. John TG, Greig JD, Carter DC, et al. Carcinoma of the pancreatic head and periampullary region (Tumor staging with laparoscopy and laparoscopic ultrasonography). Ann Surg. 1995;221:156–164
  40. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg. 2003;237:66–73
  41. Menack MJ, Spitz JD, Arregui ME. Staging of pancreatic and ampullary cancers for resectability using laparoscopy with laparoscopic ultrasound. Surg Endosc. 2001;15:1129–1134
  42. Warshaw AL, Fernandez-del CC. Pancreatic carcinoma. N Engl J Med. 1992;326:455–465
  43. Rivera JA, Fernandez-del CC, Warshaw AL. The preoperative staging of pancreatic adenocarcinoma. Adv Surg. 1996;30:97–122
  44. Karachristos A, Scarmeas N, Hoffman JP. CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer. J Gastrointest Surg. 2005;9:1286–1292
  45. Weber SM, Lee FT. Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation. Oncology (Williston Park). 2005;19:27–32
  46. Rubin SC, Dulaney ED, Markman M, et al. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol. 1988;71:851–853
  47. Grimshaw RN, Tupper WC, Fraser RC, et al. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol. 1990;36:97–100
  48. Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg. 1999;188:649–655
  49. Makary MA, Warshaw AL, Centeno BA, et al. Implications of peritoneal cytology for pancreatic cancer management. Arch Surg. 1998;133:361–365
  50. Nieveen van Dijkum EJ, de Wit LT, van Delden OM, et al. The efficacy of laparoscopic staging in patients with upper gastrointestinal tumors. Cancer. 1997;79:1315–1319
  51. Conlon KC, Dougherty E, Klimstra DS, et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996;223:134–140
  52. Barrat C, Champault G, Catheline JM. [Is laparoscopic evaluation of digestive cancers legitimate? A prospective study of 109 cases]. Ann Chir. 1998;52:602–606
  53. Pearlstone DB, Mansfield PF, Curley SA, et al. Laparoscopy in 533 patients with abdominal malignancy. Surgery. 1999;125:67–72
  54. Burke EC, Karpeh MS, Conlon KC, et al. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225:262–267
  55. Shoup M, Brennan MF, Karpeh MS, et al. Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity. Ann Surg Oncol. 2002;9:632–636
  56. Conlon KC, Karpeh MS. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol. 1996;23:347–351
  57. Bozzetti F. Rationale for extended lymphadenopathy in gastrectomy for carcinoma. J Am Coll Surg. 1995;180:505–508
  58. Doglietto G, Pacelli F, Caprino P. Surgery: independent prognostic factor in curable and far advanced gastric carcinoma. World J Surg. 2000;24:459–463
  59. Hartgrink H, Bonenkamp H, van de Velde C. Influence of surgery on outcomes in gastric cancer. Surg Oncol Clin N Am. 2000;9:97
  60. Kim J, Kwon O, Oh S. Results of surgery on 6589 gastric cancer patients and immunohemosurgery as the best treatment of advanced gastric cancer. Ann Surg. 1992;216:269–278
  61. Hughes B, Yip D, Chao M, et al. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg. 2004;74:951–956
  62. Hundahl S, Phillips J, Menck H. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy. Cancer. 2000;88:921–932
  63. Hochwald SN, Brennan MF, Klimstra DS, et al. Is lymphadenectomy necessary for early gastric cancer?. Ann Surg Oncol. 1999;6:664–670
  64. Kim HJ, Karpeh MS, Brennan MF. Standardization of the extent of lymphadenectomy for gastric cancer: impact on survival. Adv Surg. 2001;35:203–223
  65. Hermanek P, Wittekind C. News of TNM and its use for classification of gastric cancer. World J Surg. 1995;19:491–495
  66. Boku T, Nakane Y, Okusa T, et al. Strategy for lymphadenectomy of gastric cancer. Surgery. 1989;105:585–592
  67. Karpeh M, Leon L, Klimestra D. Lymph node staging in gastric cancer: is location more important than number? (An analysis of 1038 patients). Ann Surg. 2000;232:362–371
  68. Goh P, Tekant Y, Isaac J, et al. The technique of laparoscopic Billroth II gastrectomy. Surg Laparosc Endosc. 1992;2:258–260
  69. Ohgami M, Otani Y, Kumai K, et al. Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg. 1999;23:187–192
  70. Azagra JS, Goergen M, De Simone P, et al. Minimally invasive surgery for gastric cancer. Surg Endosc. 1999;13:351–357
  71. Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4:146–148
  72. Nagai Y, Tanimura H, Takifuji K, et al. Laparoscope-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1995;5:281–287
  73. Uyama I, Sugioka A, Fujita J, et al. Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer. Gastric Cancer. 1999;2:230–234
  74. Uyama I, Sugioka A, Fujita J, et al. Completely laparoscopic extraperigastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric Cancer. 1999;2:186–190
  75. Uyama I, Sugioka A, Matsui H, et al. Laparoscopic D2 lymph node dissection for advanced gastric cancer located in the middle or lower third portion of the stomach. Gastric Cancer. 2000;3:50–55
  76. Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241:232–237
  77. Hashizume M, Shimada M, Tomikawa M, et al. Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system. Surg Endosc. 2002;16:1187–1191
  78. Burke EC, Karpeh MS, Conlon KC, et al. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225:262–267
  79. Lehnert T, Rudek B, Kienle P, et al. Impact of diagnostic laparoscopy on the management of gastric cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma. Br J Surg. 2002;89:471–475
  80. Possik RA, Franco EL, Pires DR, et al. Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases. Cancer. 1986;58:1–6
  81. Goh PM, So JB. Role of laparoscopy in the management of stomach cancer. Semin Surg Oncol. 1999;16:321–326
  82. Stell DA, Carter CR, Stewart I, et al. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg. 1996;83:1260–1262
  83. O’Brien MG, Fitzgerald EF, Lee G, et al. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol. 1995;90:2191–2194
  84. Sarela AI, Lefkowitz R, Brennan MF, et al. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 2006;191:134–138
  85. Lowy AM, Mansfield PF, Leach SD, et al. Laparoscopic staging for gastric cancer. Surgery. 1996;119:611–614
  86. Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Peritoneal cytology in patients with gastric cancer exposed to the serosa—a proposed new classification based on the local and distant cytology. Hepatogastroenterology. 2003;50:1183–1186
  87. Bonenkamp JJ, Songun I, Hermans J, et al. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996;83:672–674
  88. Wilkiemeyer MB, Bieligk SC, Ashfaq R, et al. Laparoscopy alone is superior to peritoneal cytology in staging gastric and esophageal carcinoma. Surg Endosc. 2004;18:852–856
  89. Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg. 1999;178:256–262
  90. Ribeiro U, Gama-Rodrigues JJ, Safatle-Ribeiro AV, et al. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg. 1998;2:244–249
  91. Burke EC, Karpeh MS, Conlon KC, et al. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol. 1998;5:411–415
  92. Bentrem D, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12:347–353
  93. Ribeiro U, Safatle-Ribeiro AV, Zilberstein B, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?. J Gastrointest Surg. 2006;10:170–176discussion.
  94. de Manzoni G, Verlato G, Di Leo A, et al. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg. 2006;30:579–584
  95. Itoh H, Oohata Y, Nakamura K, et al. Complete ten-year postgastrectomy follow-up of early gastric cancer. Am J Surg. 1989;158:14–16
  96. Adachi Y, Shiraishi N, Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig Surg. 2002;19:333–339
  97. Farley DR, Donohue JH. Early gastric cancer. Surg Clin North Am. 1992;72:401–421
  98. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–229
  99. Tanabe S, Koizumi W, Mitomi H, et al. Usefulness of EMR with an oblique aspiration mucosectomy device compared with strip biopsy in patients with superficial esophageal cancer. Gastrointest Endosc. 2004;59:558–563
  100. Suzuki H, Ikeda K. Endoscopic mucosal resection and full thickness resection with complete defect closure for early gastrointestinal malignancies. Endoscopy. 2001;33:437–439
  101. Noh SH, Hyung WJ, Cheong JH. Minimally invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol. 2005;90:188–193
  102. Ohashi S. Laparoscopic intraluminal (intragastric) surgery for early gastric cancer (A new concept in laparoscopic surgery). Surg Endosc. 1995;9:169–171
  103. Yamashita Y, Maekawa T, Sakai T, et al. Transgastrostomal endoscopic surgery for early gastric carcinoma and submucosal tumor. Surg Endosc. 1999;13:361–364
  104. Kim MC, Kim HH, Jung GJ. Surgical outcome of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Eur J Surg Oncol. 2005;31:401–405
  105. Adachi Y, Suematsu T, Shiraishi N, et al. Quality of life after laparoscopy-assisted Billroth I gastrectomy. Ann Surg. 1999;229:49–54
  106. Adachi Y, Shiraishi N, Shiromizu A, et al. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg. 2000;135:806–810
  107. Shiraishi N, Adachi Y, Kitano S, et al. Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy. Br J Surg. 1999;86:541–544
  108. Weber KJ, Reyes CD, Gagner M, et al. Comparison of laparoscopic and open gastrectomy for malignant disease. Surg Endosc. 2003;17:968–971
  109. Fujiwara M, Kodera Y, Kasai Y, et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg. 2003;196:75–81
  110. Miura S, Kodera Y, Fujiwara M, et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg. 2004;198:933–938
  111. Kitano S, Shiraishi N, Fujii K, et al. A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery. 2002;131:S306–S311
  112. Fujimoto S, Takahashi M, Mutou T. Clinicopathologic characteristics of gastric cancer patients with cancer infiltration at surgical margins at gastrectomy. Anticancer Res. 1997;17:689–694
  113. Group BSC. Resection line disease in stomach cancer. BMJ. 1984;289:601–603
  114. Gall C, Rieger N, Wattchow D. Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence. Aust N Z J Surg. 1996;66:734–737
  115. Songun I, Bonenkamp J, Hermans J. Prognostic value of resection line involvement in patients undergoing curative resection for gastric cancer. Eur J Cancer. 1996;32A:433–437
  116. Kim S, Karpeh M, Klimestra D. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg. 1999;3:24–33
  117. Yoo C, Noh S, Shin D. Recurrence following curative resection for gastric carcinoma. Br J Cancer. 2000;87:236–242
  118. Maehara Y, Hasuda S, Koga T. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Cancer. 2000;87:353–357
  119. Minsky B. The role of radiation therapy in gastric cancer. Semin Oncol. 1996;23:390–396
  120. Gunderson L, Sosin H. Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic looks): clinicopathologic correlation and implications for adjuvent therapy. Int J Radiat Oncol Biol Phys. 1982;8:1–11
  121. Wisbeck W, Bevher E, Russell A. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol. 1986;7:13–18
  122. Iivonen M, Mattila J, Nordback I. Long-term follow-up of patients with jejunal pouch reconstruction after total gastrectomy (A randomized prospective study). Scand J Gastroenterol. 2000;35:679–685
  123. Landry J, Tepper J, Wood W. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys. 1990;19:1357–1362
  124. Hughes ES, McDermott FT, Polglase AL, et al. Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis Colon Rectum. 1983;26:571–572
  125. Alexander RJ, Jaques BC, Mitchell KG. Laparoscopically assisted colectomy and wound recurrence. Lancet. 1993;341:249–250
  126. Zmora O, Weiss EG. Trocar site recurrence in laparoscopic surgery for colorectal cancer (Myth or real concern?). Surg Oncol Clin N Am. 2001;10:625–638
  127. Pearlstone DB, Feig BW, Mansfield PF. Port site recurrences after laparoscopy for malignant disease. Semin Surg Oncol. 1999;16:307–312

PII: S0011-3840(07)00019-6

doi: 10.1067/j.cpsurg.2007.02.002

Current Problems in Surgery
Volume 44, Issue 4 , Pages 228-269 , April 2007

Article Tools

* Image Usage & Resolution